Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04216173 · ClinicalTrials.gov registry record · NA

Acupuncture for Headache Post-Traumatic Brain Injury: A Feasibility Study

A NA study, sponsored by University of Washington.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT04216173: Clinical Trial NA study, sponsored by University of Washington.

NCT04216173 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04216173, a NA study, was terminated before completion, sponsored by University of Washington.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

This study evaluates and addresses challenges to implementing an acupuncture intervention for adults who have headaches after sustaining a moderate traumatic brain injury. Eligible participants will be recruited from Seattle and the surrounding areas to receive weekly acupuncture for 12 consecutive weeks. Participants will complete questionnaires to assess headache impact, depression, health-related quality of life, and cognitive function at the beginning of the study and every two weeks for the duration of the study. Participants will participate in structured interviews after the study for their views on the acceptability and tolerability of the study protocol.

Primary Outcome

Retention rate will be evaluated by the proportion of weekly acupuncture sessions completed per participant over the course of 12 consecutive weeks.

Interventions

  • OTHER Acupuncture

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2020-02-06
Est. Completion 2020-03-12
Phase NA
University of Washington

1,048 total trials

Why NCT04216173 stopped before completion

NCT04216173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.

NCT04216173 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04216173 about?

NCT04216173 is a clinical study titled "Acupuncture for Headache Post-Traumatic Brain Injury: A Feasibility Study". This study evaluates and addresses challenges to implementing an acupuncture intervention for adults who have headaches after sustaining a moderate traumatic brain injury. Eligible participants will be recruited from Seattle and the surrounding areas to receive weekly acupuncture for 12 consecutive ...

What is the current status of trial NCT04216173?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-02-06. Estimated completion is 2020-03-12.

What interventions are being tested in trial NCT04216173?

The interventions under investigation include: Acupuncture (OTHER).

Who is sponsoring clinical trial NCT04216173?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04216173's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04216173, the US trial registry maintained by the National Library of Medicine. NCT04216173 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.